In-Silico Capabilities

Research-Grade AI for Oncology

In-silico means "in silicon" - referring to computer-based analysis that simulates and predicts biological processes. Our research-grade AI platform transforms complex genomic data into actionable insights for oncology research and clinical decision support.

Research Use Only (RUO)

All outputs are for research purposes and not for diagnostic use. Built with transparent methodology and auditable provenance.

Available Now (Research-Mode)

Live capabilities with transparent evidence metrics, confidence scores, and auditable provenance

Chemo Co‑Pilot: In‑Silico Chemotherapy Guidance

Core Capability

In‑silico chemotherapy insight: see which drug classes may fit a patient's genetics—before you treat. Clear signals, confidence, and sources (research‑mode).

Evidence (Core)

Confidence: Auditable Provenance

Tier: Supported/Consider/Insufficient

Sources: ClinVar + Literature

Provenance: run_id, profile

Target Audience

For Medical Oncologists

CRISPR Intelligence: Advanced Therapeutic R&D Platform

Core Capability

An advanced R&D platform for designing, predicting, and validating CRISPR-based therapeutics with unparalleled precision and speed.

Evidence (Core)

Confidence: 0.957 (ClinVar AUROC)

Tier: Supported/Consider/Insufficient

Sources: ClinVar + Literature

Provenance: run_id, profile

Target Audience

For R&D Scientists

Clinical Trials Co‑Pilot: In‑Silico Trial Matching

Core Capability

Find matching trials in minutes. Clear eligibility and a shareable one‑pager (research‑mode).

Evidence (Core)

Confidence: Current Data Access

Tier: Supported/Consider/Insufficient

Sources: ClinVar + Literature

Provenance: run_id, profile

Target Audience

For Clinicians & Trial Offices

Pathway View: What's Driving This?

Core Capability

A simple biology story for each case: which pathways look most involved, and how that ties to therapy (research‑mode).

Evidence (Core)

Confidence: 95.7% AUROC

Tier: Supported/Consider/Insufficient

Sources: ClinVar + Literature

Provenance: run_id, profile

Target Audience

For Clinicians

Therapy Fit: In‑Silico Drug Ranking

Core Capability

See which drug classes may fit a patient's genetics—before treatment. Clear ranking, confidence, and sources (research‑mode).

Evidence (Core)

Confidence: 95.7% AUROC

Tier: Supported/Consider/Insufficient

Sources: ClinVar + Literature

Provenance: run_id, profile

Target Audience

For Medical Oncologists

Toxicity Risk (Germline): In‑Silico Side‑Effect Hints

Core Capability

See simple, genetics‑aware side‑effect hints to plan conservatively—before treatment (research‑mode).

Evidence (Core)

Confidence: 95.7% AUROC

Tier: Supported/Consider/Insufficient

Sources: ClinVar + Literature

Provenance: run_id, profile

Target Audience

For Radiation/Medical Oncology